Suzanne Topalian, Johns Hopkins Medicine, Baltimore, USA
Dr. Topalian

Dr. Topalian is the Bloomberg~Kimmel Professor of Cancer Immunotherapy at Johns Hopkins University School of Medicine. She is a physician-scientist whose studies have been foundational in developing cancer immunotherapy. She trained at Tufts University School of Medicine, Thomas Jefferson University Hospital, and the National Cancer Institute. She joined Johns Hopkins in 2006, leading its Melanoma Program. Her research focuses on manipulating “immune checkpoints” such as PD-1 in cancer therapy. She was named one of Nature’s 10 in 2014, received ASCO’s Karnofsky Award in 2015, and was elected to the National Academy of Medicine in 2017, for landmark discoveries in immunotherapy. Her work has opened new avenues of investigation establishing immunotherapy as a pillar of oncology.

« Go Back

Register Now Submit Abstract
Supporting Publications
Premium Sponsor
Silver Sponsor
Cell Mentor

Financial support available